Achieve Life Sciences (ACHV) Cash from Financing Activities (2010 - 2026)

Achieve Life Sciences' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $21000.0 for Q1 2026.

• Quarterly Cash from Financing Activities changed N/A year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (changed N/A YoY) and the FY2025 annual result came in at $51.5 million, up 6.18% from the prior year.
• Cash from Financing Activities was $21000.0 for Q1 2026 at Achieve Life Sciences, down from $6.3 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $56.1 million in Q1 2024 and bottomed at -$8.1 million in Q3 2024.
• A 5-year average of $7.2 million and a median of $682000.0 in 2024 frame the typical range for Cash from Financing Activities.
• Peak annual rise in Cash from Financing Activities reached 119282.98% in 2024, while the deepest fall reached 101.0% in 2024.
• Achieve Life Sciences' Cash from Financing Activities stood at $17.7 million in 2022, then dropped by 14.01% to $15.2 million in 2023, then slumped by 95.52% to $682000.0 in 2024, then jumped by 818.33% to $6.3 million in 2025, then tumbled by 99.66% to $21000.0 in 2026.
• Business Quant data shows ACHV's Cash from Financing Activities at $21000.0 in Q1 2026, $6.3 million in Q4 2025, and $4.0 million in Q3 2025.